Capital Fund Management S.A. Bluebird Bio, Inc. Call Options Transaction History

Capital Fund Management S.A.

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 13, 2020	SELL	$27.12 - $45.97 $227,808 - $386,148	-8,400 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$26.16 - $63.5 $141,264 - $342,900	5,400 Added 180.0%	8,400 $250,000
Q3 2019 Nov 13, 2019	SELL	$59.47 - $93.1 $1.75 Million - $2.74 Million	-29,400 Reduced 90.74%	3,000 $275,000
Q1 2019 May 13, 2019	BUY	$64.44 - $104.11 $1.48 Million - $2.38 Million	22,900 Added 241.05%	32,400 $5.1 Million
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $506,502 - $669,693	5,700 Added 150.0%	9,500 $1.39 Million
Q2 2018 Aug 14, 2018	SELL	$99.64 - $127.59 $2.28 Million - $2.92 Million	-22,900 Reduced 85.77%	3,800 $596,000
Q1 2018 May 15, 2018	SELL	$105.8 - $150.94 $232,760 - $332,068	-2,200 Reduced 7.61%	26,700 $4.56 Million
Q4 2017 Feb 09, 2018	BUY	$81.25 - $130.7 $2.35 Million - $3.78 Million	28,900	28,900 $5.15 Million

150

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $765M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.